Hindistonda 400 milliondan ortiq surunkali kasallikka chalingan bemorlar bor va bu uni dunyodagi eng yirik farmatsevtika bozorlaridan biriga aylantiradi. Aksar e-aptekalar tez yetkazib berish poygasida bo\u2018lsa-da, eng katta muammo \u2014 dori narxining qimmatligi \u2014 hal etilmay qolmoqda.<\/p>\n\n\n\n
2019-yilda tashkil etilgan Truemeds<\/strong> esa boshqa yo\u2018lni tanladi: bemorlarga qimmat brend dori vositalari o\u2018rniga sifat jihatdan teng, ammo ancha arzon generik preparatlarni tavsiya qilish. Bu yondashuv natija berdi \u2014 kompaniya yaqinda $85 million<\/strong> jalb qildi va bahosi ikki yil oldingi $110 milliondan $400 milliondan ortiqqa<\/strong> ko\u2018tarildi.<\/p>\n\n\n\n Yangi moliyalashtirish raundiga Accel<\/strong> boshchilik qildi, shuningdek, Peak XV Partners<\/strong>, WestBridge Capital<\/strong> va InfoEdge Ventures<\/strong> ham ishtirok etdi. Mablag\u2018ning $65 millioni asosiy investitsiya, $20 millioni esa ikkilamchi bitimlardan kelib tushdi.<\/p>\n\n\n\n Truemeds bozorga kirgan paytda Hindiston onlayn-apteka segmenti allaqachon katta o\u2018yinchilar bilan to\u2018la edi. Masalan, PharmEasy<\/strong>\u2019ning qiymati $5,6 milliarddan $600 milliondan pastga tushdi, 1mg<\/strong> esa Tata Digital tomonidan sotib olindi. Truemeds esa to\u2018g\u2018ridan-to\u2018g\u2018ri raqobatga kirishmadi, balki generik dori segmentiga e\u2019tibor qaratdi.<\/p>\n\n\n\n \u201cBemorlarni arzonroq, sifatli alternativalar mavjudligiga ishontirish qiyin, ammo zarur. Hech kim bu bo\u2018shliqni to\u2018ldirmayotgan edi,\u201d \u2014 deydi hamkor asoschi Akshat Nayyar<\/strong>.<\/p>\n\n\n\n Bozor ishtirokchilari chegirmalarni kamaytirgan bir paytda, Truemeds ularni oshirdi: o\u2018tgan yilda o\u2018rtacha chegirma 29% dan 32%<\/strong> gacha ko\u2018tarildi. Brendini almashtirgan foydalanuvchi uchun esa tejash 47%<\/strong> ga yetadi. Bu \u2014 ishlab chiqaruvchilar bilan chuqur hamkorlik va talab prognozini texnologiya orqali aniq rejalashtirish hisobiga.<\/p>\n\n\n\n Kompaniya yillik 10\u201312 million<\/strong> maslahat o\u2018tkazadi va maxsus algoritm orqali eng mos generik alternativalarni taklif qiladi. Endi esa mijoz xulqini tahlil qiluvchi AI-based shaxsiylashtirilgan maslahat<\/strong> tizimini ishga tushirish, shuningdek, diagnostika bozoriga kirish<\/strong> niyatida. Dastlabki bosqich sifatida, milliy laboratoriyalar bilan hamkorlikda 2-darajali shaharlarda tahlil xizmatlarini sinovdan o\u2018tkazish rejalashtirilmoqda.<\/p>\n\n\n\n Bundan tashqari, kompaniya omborlarini bir yil ichida 19 tadan 76 tagacha<\/strong> ko\u2018paytirishni maqsad qilgan.<\/p>\n\n\n\n Asosiy missiya o\u2018zgarmaydi:<\/strong> Hindistonda sog\u2018liqni saqlash xarajatlarini bemorlar uchun arzonlashtirish. Dastlab dorilar orqali boshlangan bu model, endi diagnostika va boshqa segmentlarga ham yoyilishi kutilmoqda.<\/p>\n","protected":false},"excerpt":{"rendered":" Hindistonda 400 milliondan ortiq surunkali kasallikka chalingan bemorlar bor va bu uni dunyodagi eng yirik farmatsevtika bozorlaridan biriga aylantiradi. Aksar e-aptekalar tez yetkazib berish poygasida bo\u2018lsa-da, eng katta muammo \u2014 dori narxining qimmatligi \u2014 hal etilmay qolmoqda. 2019-yilda tashkil etilgan Truemeds esa boshqa yo\u2018lni tanladi: bemorlarga qimmat brend dori vositalari o\u2018rniga sifat jihatdan teng, ammo […]<\/p>\n","protected":false},"author":3,"featured_media":8370,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_override_bookmark_settings":[],"jnews_paywall_metabox":[],"jnews_override_counter":[],"jnews_podcast_option":[],"jnews_podcast_series":[],"footnotes":""},"categories":[116],"tags":[],"jnews-series":[],"class_list":["post-8372","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-startaplar"],"_links":{"self":[{"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/posts\/8372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/comments?post=8372"}],"version-history":[{"count":3,"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/posts\/8372\/revisions"}],"predecessor-version":[{"id":8375,"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/posts\/8372\/revisions\/8375"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/media\/8370"}],"wp:attachment":[{"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/media?parent=8372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/categories?post=8372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/tags?post=8372"},{"taxonomy":"jnews-series","embeddable":true,"href":"https:\/\/pivot.uz\/uz\/wp-json\/wp\/v2\/jnews-series?post=8372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Bitim tafsilotlari<\/h5>\n\n\n\n
Q crowded bozorga kirishda strategik burilish<\/h5>\n\n\n\n
O\u2018sish raqamlarda<\/h5>\n\n\n\n
\n
Tezlik o\u2018rniga tejash<\/h5>\n\n\n\n
Kelgusi rejalar: AI va diagnostika<\/h5>\n\n\n\n